Hello guest
Your basket is empty
We provide two pathways to the content. Thematic (chapters that address certain themes, e.g. cultivation, regardless of crop or animal type) and Product (chapters that relate to a specific type of crop or animal). Choose the most applicable route to find the right collection for you. 
 
Can’t find what you are looking for? Contact us and let us help you build a custom-made collection. 
You are in: All categories > Open Access
Use the Contact form to discuss the best purchasing method for you... Start building your collection today!

Development and scale-up of bioprotectants to keep staple foods safe from aflatoxin contamination in Africa

Code: 9781801462259
Ranajit Bandyopadhyay, Alejandro Ortega-Beltran, Matieyedou Konlambigue, Lawrence Kaptoge and Titilayo D. O. Falade, International Institute of Tropical Agriculture, Nigeria; and Peter J. Cotty, Ocean University of China, China

Chapter synopsis: Aflatoxins pose a significant public health risk, decrease productivity and profitability and hamper trade. To minimize aflatoxin contamination a biocontrol technology based on atoxigenic strains of Aspergillus flavus that do not produce aflatoxin is used widely in the United States. The technology, with the generic name Aflasafe, has been improved and adapted for use in Africa. Aflasafe products have been developed or are currently being developed in 20 African countries. Aflatoxin biocontrol is being scaled up for use in several African countries through a mix of public, private, and public-private interventions. Farmers in several countries have commercially treated nearly 400,000 ha of maize and groundnut achieving >90% reduction in aflatoxin contamination. This chapter summarizes the biology of aflatoxin-producing fungi and various factors affecting their occurence, including climate change. Various management practices for aflatoxin mitigation are then discussed. These include biological control, which is increasingly being adopted by farmers in several countries. We discuss biocontrol product development and commercialization in various African countries. Subsequently, we highlight some barriers to adoption and other challenges.

DOI: 10.19103/AS.2021.0093.16

Click here to download
£0.00
Table of contents 1 Introduction 2 Aspergillus biology and aflatoxin epidemiology 3 Aflatoxin management options 4 Biocontrol product development and the registration process in Africa 5 Manufacturing development 6 Barriers preventing adoption and how to overcome them 7 Scaling up aflatoxin biocontrol technology 8 Current challenges and needs 9 Some final thoughts 10 Conclusion 11 Where to look for further information 12 Acknowledgement 13 References

Also in Open Access

Our site uses cookies. For more information, see our cookie policy. Accept cookies and close
Reject cookies Manage settings